60 Degrees pharma focuses on Malaria treatment and clinical trials #health #malariatreatment

By Proactive Investors / August 30, 2024 / www.youtube.com / Article Link


60 Degrees Pharmaceuticals CEO Geoff Dow discussed the challenges facing the company in the current market environment.

Recent News

US tariff decision expected to be major copper catalyst
July 07, 2026 / www.canadianminingreport.com

Gold stocks rebound from near lows
July 07, 2026 / www.canadianminingreport.com

Gold stocks decline as metal price drops
June 29, 2026 / www.canadianminingreport.com

Tech takes a hit on South Korea semiconductor decline

June 29, 2026 / www.canadianminingreport.com

Gold stocks rise even as metal drops for second week
June 22, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok